✦ LIBER ✦

Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial

✍ Scribed by William J Sandborn; Daniel H Present; Kim L Isaacs; Douglas C Wolf; Eugene Greenberg; Stephen B Hanauer; Brian G Feagan; Lloyd Mayer; Therese Johnson; Joseph Galanko; Christopher Martin; Robert S Sandler

Book ID: 119426658
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 130 KB
Volume: 125
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(03)00877-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topical tacrolimus in the treatment of p

Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial

✍ Ailsa L. Hart; Sophie Plamondon; Michael A. Kamm 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Background: The aim of this study is to evaluate the efficacy of topical tacrolimus in treating perianal crohn's disease. ## Methods: Nineteen patients, stratified into 7 with ulcerating, and 12 with fistulizing, perianal crohn's disease were randomized to topical tacrolimus 1 mg/g (1 g ointme

Ciprofloxacin or metronidazole for the t

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study

✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with

Oral Spherical Adsorptive Carbon for the

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Fukuda, Yoshihiro; Takazoe, Masakazu; Sugita, Akira; Kosaka, Tadashi; Kinjo, Fuk 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 431 KB

Infliximab Plus Azathioprine for Steroid

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

✍ Marc LÉmann; Jean–Yves Mary; Bernard Duclos; Michel Veyrac; Jean–Louis Dupas; Je 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 251 KB

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease

✍ Stefan Schreiber; Paul Rutgeerts; Richard N. Fedorak; Munaa Khaliq–Kareemi; Mich 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 228 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des